ACADIA Pharmaceuticals, Inc. (ACAD)
24.73
+0.74
(+3.08%)
USD |
NASDAQ |
Feb 23, 16:00
24.75
+0.02
(+0.08%)
After-Hours: 19:59
ACADIA Pharmaceuticals EPS Diluted (Quarterly) : 0.4206 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1193 |
| Dynavax Technologies Corp. (DELISTED) | 0.2063 |
| Axsome Therapeutics, Inc. | -0.9442 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 71.78M |
| Revenue (Quarterly) | 278.63M |
| Total Expenses (Quarterly) | 206.85M |
| Enterprise Value | 3.392B |
| Gross Profit Margin (Quarterly) | 92.23% |
| Profit Margin (Quarterly) | 25.76% |
| Earnings Yield | 6.28% |
| Operating Earnings Yield | 2.27% |
| Normalized Earnings Yield | 6.285 |